Compromised breast flap treated with leech therapy, hyperbaric oxygen, pentoxifylline and topical nitroglycerin: A case report
Case report published in Undersea Hyperb Med (2015)
Abstract
INTRODUCTION: Hyperbaric oxygen (HBO2) is often indicated in compromised surgical flaps. Although limited to animal models and human case reports, the utilization of leech therapy (Hirudo medicinalis) with HBO2 provides better outcomes than each modality alone. Topical nitroglycerin and pentoxifylline are also frequently used adjunctively for compromised flaps. We present a case of successful breast flap salvage utilizing a combination of leech therapy, HBO2, topical nitroglycerin and pentoxifylline. CASE REPORT: A 34-year-old female, one day post-status cosmetic breast reduction mammoplasty developed a dusky discoloration of the left nipple areolar complex, indicating imminent flap failure. The patient was immediately treated with topical nitroglycerin, oral pentoxifylline, and referred for HBO2. After her first HBO2 treatment, there was clinical improvement to the superior portion of the areolar flap, with little improvement inferiorly where the discoloration had remained essentially unchanged. To address this, we added leech therapy and discontinued the topical nitroglycerin. Ceftriaxone for Aeromonas prophylaxis was started, and leeches were attached two at a time and removed from the area once feeding had ceased. These were applied three times per day for three days while receiving HBO2 twice per day for six days. The patient's flap improved and completely healed by Week 8 without need for further surgery. CONCLUSION: This is the first case to our knowledge of successful breast flap salvage using a combination of leech therapy, HBO2, topical nitroglycerin and pentoxifylline.
Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.
Resumen
34-year-old female post-cosmetic breast reduction with compromised areolar flap salvaged by combined leech therapy, hyperbaric oxygen, pentoxifylline, and topical nitroglycerin with complete healing by 8 weeks.
Por qué esto importa para la hirudoterapia
Este reporte de caso describe a una mujer de 34 años que desarrolló una coloración oscura del complejo pezón-areola izquierdo un día después de una mamoplastia estética de reducción mamaria, lo que indicaba una falla inminente del colgajo. Fue tratada con una combinación de terapia con sanguijuelas (Hirudo medicinalis, dos sanguijuelas a la vez, tres veces al día durante tres días), oxígeno hiperbárico, pentoxifilina y nitroglicerina tópica inicial, iniciándose ceftriaxona para profilaxis frente a Aeromonas; el colgajo sanó completamente hacia la semana 8 sin requerir cirugía adicional. Para el dominio de ASH, este caso documenta directamente el uso de la hirudoterapia como adyuvante para el rescate de un colgajo mamario comprometido, incluyendo atención explícita a la profilaxis contra Aeromonas — contenido de relevancia práctica. La limitación clara es que se trata de un reporte de caso único sin grupo control y con terapia combinada, por lo que no puede atribuirse causalidad exclusivamente a la terapia con sanguijuelas ni se puede reclamar generalizabilidad.
Citación
Contexto clínico relacionado
Explore cómo esta investigación se conecta con la práctica clínica
Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: 18 de junio de 2026